Single-dose pharmacokinetic and pharmacodynamic comparison of polymer- matrix (Slow Trasicor) and Oros dosage forms of oxprenolol in healthy volunteers.-Reference-Cited by-同舟云学术

Single-dose pharmacokinetic and pharmacodynamic comparison of polymer- matrix (Slow Trasicor) and Oros dosage forms of oxprenolol in healthy volunteers.

Published:1985-04 Issue:S2 Volume:19 Page:171S-175S
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Bennett PN,Bennett J,Bradbrook I,Francis J,John VA,Rogers H,Turner P,Warrington SJ

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1985.tb02758.x/fullpdf

Reference5 articles.

1. Relation between plasma concentrations and cardiovascular effects of oral oxprenolol in man;Brunner;Eur. J. clin. Pharmac.,1975

2. Simplified method for the determination of oxprenolol and other β-receptor blocking agents in biological fluids by gas-liquid chromatography;Degen;J. Chromatogr.,1976

3. Pharmacokinetics of oxprenolol in normal subjects;Mason;Clin. Pharmac. Ther.,1976

4. Osmotic delivery systems for the β-adrenoceptor antagonists, metoprolol and oxprenolol: design and evaluation of systems for once-daily administration;Theeuwes;Br. J. clin. Pharmac.,1985

5. The generalization of Student's problem when several different population variances are involved;Welch;Biometrika,1947

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relative bioavailability of oral sustained-release and regular-release oxprenolol tablets at steady-state;Biopharmaceutics & Drug Disposition;1991-10

2. Concentration‐effect relationships for oxprenolol in patients with essential hypertension.;British Journal of Clinical Pharmacology;1988-05

3. Evaluation of two oxprenolol oral osmotic (OROS) delivery systems in patients with essential hypertension;European Journal of Clinical Pharmacology;1988

4. Evaluation of oxprenolol slow release and osmotic release by exercise testing and ambulatory electrocardiographic monitoring in patients with chronic stable angina pectoris;European Journal of Clinical Pharmacology;1987

5. Twenty-four hour effects of oxprenolol oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion;European Journal of Clinical Pharmacology;1986-07